Toggle menu
  • Login or Sign Up
  • 0
    • USD
      • British Pound
      • US Dollar
  • Biopharma Research
    Reset Search ×
    • 0
    Reset Search ×
    • USD
      • British Pound
      • US Dollar

      Main Menu

    • OUR SERVICES
      • Custom Research Services
      • Laboratory End User Surveys
    • ABOUT US
    • CONTACT US
    • Shop By Category

    • All Diagnostics Markets
    • PARTNERING, LICENSING, M&A
    • Multiplex Diagnostics
    • Therapeutics
    • Genomics
    • Cancer Diagnostics
    • Infectious Disease Diagnostics
    • COVID-19 Diagnostics
    • Point of Care (POC) Diagnostics
    • Direct-to-Consumer (DTC) Diagnostics
    • Rapid Diagnostics
    • Laboratory Techniques
    • Medical Laboratory Services
    • Calibration
    • USD
      • British Pound
      • US Dollar
    • Gift Certificates
    • Login or Sign Up

    Market ReportsMarket Reports

    Shop by Category

  • All Diagnostics Markets
  • PARTNERING, LICENSING, M&A
  • Multiplex Diagnostics
  • Therapeutics
  • Genomics
  • Cancer Diagnostics
  • Infectious Disease Diagnostics
  • COVID-19 Diagnostics
  • Point of Care (POC) Diagnostics
  • Direct-to-Consumer (DTC) Diagnostics
  • Rapid Diagnostics
  • Laboratory Techniques
  • Medical Laboratory Services
  • Calibration

    • Main Menu

    • OUR SERVICES
      • Custom Research Services
      • Laboratory End User Surveys
    • ABOUT US
    • CONTACT US
    • Shop By Category

    • All Diagnostics Markets
    • PARTNERING, LICENSING, M&A
    • Multiplex Diagnostics
    • Therapeutics
    • Genomics
    • Cancer Diagnostics
    • Infectious Disease Diagnostics
    • COVID-19 Diagnostics
    • Point of Care (POC) Diagnostics
    • Direct-to-Consumer (DTC) Diagnostics
    • Rapid Diagnostics
    • Laboratory Techniques
    • Medical Laboratory Services
    • Calibration
    Reset Search ×
    • 0
    • Home
    • Therapeutics
    • Current Agreements: Life Science Deal Tracker Database (12 month access)
  • Current Agreements: Powerful Intelligence for Dealmakers
  • Current Agreements: Powerful Intelligence for Dealmakers
  • Current Agreements: Powerful Intelligence for Dealmakers Current Agreements: Powerful Intelligence for Dealmakers

    Current Agreements: Life Science Deal Tracker Database (12 month access)

    $5,995.00
    (You save )
    Write a Review

    SKU:
    CA-1U
    Availability:
    Access will be granted on receipt of cleared payment

    Adding to cart… category.add_cart_announcement

    Share This Article

    • Overview

    Product Description

    Current Agreements: Life Science Deal Tracker Database (12 month access)

    • Update frequency: Daily / real-time
    • Deal count: 60,000+ deal records since 2000
    • Format: Online database access

    Request a sample or personalized screenshot

    Current Agreements is the industry-leading premium subscription database providing instant and affordable access to comprehensive deal metrics and actual contract documents covering partnering and M&A activity since 2000 across the Life Sciences sector.

    Current Agreements allows you to:

    • Identify companies partnering in your interest area
    • Discover actual contract terms between alliance partners
    • Benchmark partnering payment deal terms
    • Track competitor deal making activity
    • Access detailed financial data
    • Monitor deal trends in your areas of interest
    • Review thousands of alliance contract documents

    Deal records are categorized using the following high-level categorization, with additional detailed sub-categorization for Therapy and Technology areas (for example 'infectious diease molecular diagnostics' or 'precision oncology'):

    INDUSTRY THERAPY AREA TECHNOLOGY DEAL COMPONENT DEVELOPMENT STAGE
    Big Pharma Anesthesia Antibiotics Asset purchase Discovery
    Pharmaceuticals Cardiovascular Antibodies Assignment Preclinical
    Biotech Central nervous system Bioinformatics Co-development Phase I
    Diagnostics Cosmetic products Biologicals Co-market Phase II
    Drug delivery Dental Biomarkers Co-promotion Phase III
    Medical devices Dermatology Biomaterials Collaborative R&D Regulatory
    Consumer health Gastrointestinal Biosimilars Contract service Marketed
    Specialty pharma Genetic disorders Cell culture CRADA Formulation
    Generic pharma Genitourinary Cell therapy Cross-licensing  
    Agricultural Gynecology Companion diagnostics Development  
    Animal health Hematology Compound library Distribution  
    Academic Hospital care Devices Equity purchase  
    Non-profit Immunology Discovery tools Evaluation  
    Government Infectives DNA probes Grant  
    Financial Inflammatory Drug delivery Joint venture  
    Research tools Metabolic Epigenetics Licensing  
    Service companies Musculoskeletal Gene therapy Litigation  
      Obstretics Genomics Loan  
      Oncology Glycomics Manufacturing  
      Ophthalmology High throughput screening Marketing  
      Psychiatry Imaging Option  
      Public health Implant Promotion  
      Respiratory In vitro diagnostics Research  
      Sensory organs Microarray Royalty financing  
      Sexual health Molecular diagnostics Settlement  
        Nanotechnology Spin out  
        Organ regeneration Sub license  
        Peptides Supply  
        Precision medicine Termination  
        Pharmacogenomics Warrant  
        Proteomics    
        Recombinant DNS    
        Regenerative medicine    
        RNA therapeutics    
        Stem cells    
        Tissue regeneration    
        Transgenics    
        Vaccines    

    The extensive deal categorization process ensures every deal is fully integrated into the database alongside similar deals. Users can also search with either simple keywords or advanced search and filter techniques.

    The database comprises more than 60,000 individual deal records providing a detailed description and categorization of each deal component. Every deal record is supported by extensive source material such as press releases, SEC disclosures and contract documents, company presentations and other company sourced disclosures where available, ensuring the user can be confident the data presented can be verified if necessary.

    Each deal record includes the following key information accessed via onscreen tabs:

    • Summary overview: key data such as deal title, date, parties to the deal
    • Termsheet: summary of key deal terms
    • Detailed categorization: deal by categories – industry sector, stage of development, therapy area, deal type,  geographic location
    • Deal financials: detailed breakdown of payment terms
    • Press release: full text as published by company(s)
    • Contract: full text of contract document as filed with regulatory body
    • PDF: Individual deal records are available for PDF download

    Each tab is completed to the fullest extent possible using publicly available sources.

    Product Videos

    Custom Field

    Product Reviews

    Write a Review

    Write a Review

    ×
    Current Agreements: Powerful Intelligence for Dealmakers
    Current Agreements: Life Science Deal Tracker Database (12 month access)
    ×
    • Recommended
    Distribution Deals in Diagnostics 2016 to 2024
    Quick view

    Distribution Deals in Diagnostics 2016-2024

    $3,995.00 - $9,995.00
    Choose Options
    Biomarkers interactive database 2021
    Quick view

    Biomarkers - Database Curated from US Oncology Trials, 2021.

    $3,500.00
    Add to Cart
    Oncology Partnering: Deal Terms, Players and Financials Oncology Partnering 2016 to 2023: Deal Terms, Players and Financials
    Quick view

    Oncology Collaboration and Licensing Deals 2019-2024

    $3,995.00 - $9,995.00
    Choose Options
    Global Antibody Partnering Terms and Agreements 2019 to 2024
    Quick view

    Antibody Collaboration and Licensing Deals 2019-2024

    $3,995.00 - $9,995.00
    Choose Options
    Sample of diagnostics deals with value disclosure Diagnostics: Collaboration and Licensing Deals
    Quick view

    Diagnostics: Collaboration and Licensing Deals 2019-2024

    $3,995.00 - $9,995.00
    Choose Options
    • Recommended
    • Distribution Deals in Diagnostics 2016 to 2024
      Quick view

      Distribution Deals in Diagnostics 2016-2024

      $3,995.00 - $9,995.00
      Choose Options
    • Biomarkers interactive database 2021
      Quick view

      Biomarkers - Database Curated from US Oncology Trials, 2021.

      $3,500.00
      Add to Cart
    • Oncology Partnering: Deal Terms, Players and Financials Oncology Partnering 2016 to 2023: Deal Terms, Players and Financials
      Quick view

      Oncology Collaboration and Licensing Deals 2019-2024

      $3,995.00 - $9,995.00
      Choose Options
    • Global Antibody Partnering Terms and Agreements 2019 to 2024
      Quick view

      Antibody Collaboration and Licensing Deals 2019-2024

      $3,995.00 - $9,995.00
      Choose Options
    • Sample of diagnostics deals with value disclosure Diagnostics: Collaboration and Licensing Deals
      Quick view

      Diagnostics: Collaboration and Licensing Deals 2019-2024

      $3,995.00 - $9,995.00
      Choose Options
    ×
    Contact Us
    Westfield House
    Millfield Lane
    Nether Poppleton
    YORK, YO26 6GA
    United Kingdom
    +44(0)1904 868857
    Accounts & Orders
    • Login or Sign Up
    • Order Status
    • Privacy Security Shipping
    Navigate
    • OUR SERVICES
    • ABOUT US
    • CONTACT US
    Join Our Mailing List

    Sign up for our newsletter to receive specials and up to date product news and releases.

    • © Biopharma Research Ltd